European Biosimilars Makers To WHO: Scrap BQ Idea Unless Study Done

The European Generic Medicines Association is urging the World Health Organization not to pursue its biological qualifier naming scheme unless it generates different options, discusses them publicly and sets up an independent user-test of the different possibilities, according to a summary of the group's stance conveyed to WHO last week. European and domestic biosimilar developers have been pressing for the use of company names, instead of a series of random letters, to more easily differentiate among biologics if regulators decide...